SSA
ANGO icon

Schonfeld Strategic Advisors’s AngioDynamics ANGO Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22,747
Closed -$214K – 2019
2025
Q1 		$214K Buy
+22,747
New +$239K ﹤0.01% 1922
2023
Q4 		– Sell
-19,703
Closed -$144K – 1852
2023
Q3 		$144K Buy
19,703
+6,903
+54% +$57.4K ﹤0.01% 1463
2023
Q2 		$134K Buy
+12,800
New +$123K ﹤0.01% 1662
2020
Q4 		– Sell
-20,555
Closed -$248K – 1549
2020
Q3 		$248K Buy
+20,555
New +$195K ﹤0.01% 1150
2020
Q1 		– Sell
-10,100
Closed -$161K – 1121
2019
Q4 		$161K Buy
+10,100
New +$154K ﹤0.01% 1189

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Schonfeld Strategic Advisors's ANGO Position: Q2 2025 in Review

Schonfeld Strategic Advisors sold out of AngioDynamics (ANGO) in Q2 2025, closing a stake of 22,747 shares — an estimated $214K sold.

Schonfeld Strategic Advisors first reported a position in ANGO in Q4 2019 and held it in 5 quarters. The position peaked at $248K in Q3 2020. 150 funds tracked by Wall St. Rank hold ANGO as of Q2 2025.

  • Schonfeld Strategic Advisors reported no remaining AngioDynamics position as of Q2 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 22,747 AngioDynamics shares in Q2 2025, an estimated $214K.
  • Schonfeld Strategic Advisors first reported a position in AngioDynamics in Q4 2019 and held it in 5 quarters.
  • Schonfeld Strategic Advisors's AngioDynamics position peaked at $248K in Q3 2020.
  • 150 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.